Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Fredrick R Schumacher^{1

2

3}, Ali Amin Al Olama^{4

5

6}, Sonja I Berndt^{7

3}, Sara Benlloch^{8

9}, Mahbubl Ahmed⁹, Edward J Saunders⁹, Tokhir Dadaev⁹, Daniel Leongamornlert⁹, Ezequiel Anokian⁹, Clara Cieza-Borrella⁹, Chee Goh⁹, Mark N Brook⁹, Xin Sheng¹⁰, Laura Fachal^{11

12}, Joe Dennis⁸, Jonathan Tyrer⁸, Kenneth Muir^{13

14}, Artitaya Lophatananon^{13

14}, Victoria L Stevens¹⁵, Susan M Gapstur¹⁵, Brian D Carter¹⁵, Catherine M Tangen¹⁶, Phyllis J Goodman¹⁶, Ian M Thompson Jr¹⁷, Jyotsna Batra^{18

19}, Suzanne Chambers^{20

21}, Leire Moya^{18

19}, Judith Clements^{18

19}, Lisa Horvath^{22

23}, Wayne Tilley²⁴, Gail P Risbridger^{25

26}, Henrik Gronberg²⁷, Markus Aly^{28

29}, Tobias Nordström^{27

30}, Paul Pharoah^{8

12}, Nora Pashayan^{12

31}, Johanna Schleutker^{32

33}, Teuvo L J Tammela³⁴, Csilla Sipeky³², Anssi Auvinen³⁵, Demetrius Albanes⁷, Stephanie Weinstein⁷, Alicja Wolk^{36

37}, Niclas Håkansson³⁶, Catharine M L West³⁸, Alison M Dunning¹², Neil Burnet³⁹, Lorelei A Mucci⁴⁰, Edward Giovannucci⁴⁰, Gerald L Andriole⁴¹, Olivier Cussenot^{42

43}, Géraldine Cancel-Tassin^{42

43}, Stella Koutros⁷, Laura E Beane Freeman⁷, Karina Dalsgaard Sorensen^{44

45}, Torben Falck Orntoft^{44

45}, Michael Borre^{45

46}, Lovise Maehle⁴⁷, Eli Marie Grindedal⁴⁷, David E Neal^{48

49

50}, Jenny L Donovan⁵¹, Freddie C Hamdy⁵⁰, Richard M Martin⁵¹, Ruth C Travis⁵², Tim J Key⁵², Robert J Hamilton⁵³, Neil E Fleshner⁵³, Antonio Finelli⁵⁴, Sue Ann Ingles¹⁰, Mariana C Stern¹⁰, Barry S Rosenstein^{55

56}, Sarah L Kerns⁵⁷, Harry Ostrer⁵⁸, Yong-Jie Lu⁵⁹, Hong-Wei Zhang⁶⁰, Ninghan Feng⁶¹, Xueying Mao⁵⁹, Xin Guo⁶², Guomin Wang⁶³, Zan Sun⁶⁴, Graham G Giles^{65

66}, Melissa C Southey⁶⁷, Robert J MacInnis^{65

66}, Liesel M FitzGerald^{65

68}, Adam S Kibel⁶⁹, Bettina F Drake⁴¹, Ana Vega¹¹, Antonio Gómez-Caamaño⁷⁰, Robert Szulkin^{71

72}, Martin Eklund²⁷, Manolis Kogevinas^{73

74

75

76}, Javier Llorca^{74

77}, Gemma Castaño-Vinyals^{73

74

75

76}, Kathryn L Penney⁷⁸, Meir Stampfer⁷⁸, Jong Y Park⁷⁹, Thomas A Sellers⁷⁹, Hui-Yi Lin⁸⁰, Janet L Stanford^{81

82}, Cezary Cybulski⁸³, Dominika Wokolorczyk⁸³, Jan Lubinski⁸³, Elaine A Ostrander⁸⁴, Milan S Geybels⁸¹, Børge G Nordestgaard^{85

86}, Sune F Nielsen^{85

86}, Maren Weischer⁸⁶, Rasmus Bisbjerg⁸⁷, Martin Andreas Røder⁸⁸, Peter Iversen⁸⁸, Hermann Brenner^{89

90

91}, Katarina Cuk⁸⁹, Bernd Holleczek⁹², Christiane Maier⁹³, Manuel Luedeke⁹³, Thomas Schnoeller⁹⁴, Jeri Kim⁹⁵, Christopher J Logothetis⁹⁵, Esther M John^{96

97}, Manuel R Teixeira^{98

99}, Paula Paulo⁹⁸, Marta Cardoso⁹⁸, Susan L Neuhausen¹⁰⁰, Linda Steele¹⁰⁰, Yuan Chun Ding¹⁰⁰, Kim De Ruyck¹⁰¹, Gert De Meerleer¹⁰¹, Piet Ost¹⁰², Azad Razack¹⁰³, Jasmine Lim¹⁰³, Soo-Hwang Teo¹⁰⁴, Daniel W Lin^{81

105}, Lisa F Newcomb^{81

105}, Davor Lessel¹⁰⁶, Marija Gamulin¹⁰⁷, Tomislav Kulis¹⁰⁸, Radka Kaneva¹⁰⁹, Nawaid Usmani^{110

111}, Sandeep Singhal^{110

111}, Chavdar Slavov¹¹², Vanio Mitev¹⁰⁹, Matthew Parliament^{110

111}, Frank Claessens¹¹³, Steven Joniau¹¹⁴, Thomas Van den Broeck^{113

114}, Samantha Larkin¹¹⁵, Paul A Townsend¹¹⁶, Claire Aukim-Hastie¹¹⁷, Manuela Gago-Dominguez^{118

119}, Jose Esteban Castelao¹²⁰, Maria Elena Martinez¹²¹, Monique J Roobol¹²², Guido Jenster¹²², Ron H N van Schaik¹²³, Florence Menegaux¹²⁴, Thérèse Truong¹²⁴, Yves Akoli Koudou¹²⁴, Jianfeng Xu¹²⁵, Kay-Tee Khaw¹²⁶, Lisa Cannon-Albright^{127

128}, Hardev Pandha¹¹⁷, Agnieszka Michael¹¹⁷, Stephen N Thibodeau¹²⁹, Shannon K McDonnell¹³⁰, Daniel J Schaid¹³⁰, Sara Lindstrom⁸², Constance Turman¹³¹, Jing Ma⁷⁸, David J Hunter¹³¹, Elio Riboli¹³², Afshan Siddiq¹³³, Federico Canzian¹³⁴, Laurence N Kolonel¹³⁵, Loic Le Marchand¹³⁵, Robert N Hoover⁷, Mitchell J Machiela⁷, Zuxi Cui¹, Peter Kraft¹³¹, Christopher I Amos^{136

137

138}, David V Conti¹⁰, Douglas F Easton^{8

12}, Fredrik Wiklund²⁷, Stephen J Chanock⁷, Brian E Henderson¹⁰, Zsofia Kote-Jarai⁹, Christopher A Haiman¹⁰, Rosalind A Eeles^{139

140}; Profile Study; Australian Prostate Cancer BioResource (APCB); IMPACT Study; Canary PASS Investigators; Breast and Prostate Cancer Cohort Consortium (BPC3); PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium; Cancer of the Prostate in Sweden (CAPS); Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS); Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium

Affiliations

¹ Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.
² Seidman Cancer Center, University Hospitals, Cleveland, OH, USA.
³ Royal Marsden NHS Foundation Trust, London, UK.
⁴ Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. aa461@medschl.cam.ac.uk.
⁵ Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. aa461@medschl.cam.ac.uk.
⁶ Royal Marsden NHS Foundation Trust, London, UK. aa461@medschl.cam.ac.uk.
⁷ Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
⁸ Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
⁹ Institute of Cancer Research, London, UK.
¹⁰ Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
¹¹ Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, Spain.
¹² Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Laboratory, University of Cambridge, Cambridge, UK.
¹³ Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK.
¹⁴ Warwick Medical School, University of Warwick, Coventry, UK.
¹⁵ Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA.
¹⁶ SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
¹⁷ CHRISTUS Santa Rosa Hospital-Medical Center, San Antonio, TX, USA.
¹⁸ Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
¹⁹ Australian Prostate Cancer Research Centre-Qld, Translational Research Institute, Brisbane, Queensland, Australia.
²⁰ Menzies Health Institute of Queensland, Griffith University, Nathan, Queensland, Australia.
²¹ Cancer Council Queensland, Fortitude Valley, Queensland, Australia.
²² Chris O'Brien Lifehouse (COBLH), Camperdown, New South Wales, Australia.
²³ Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
²⁴ Dame Roma Mitchell Cancer Research Centre, University of Adelaide, Adelaide, South Australia, Australia.
²⁵ Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Program, Department of Anatomy and Developmental Biology, Monash University, Victoria, Australia.
²⁶ Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.
²⁷ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
²⁸ Department of Urology, Karolinska University Hospital, Stockholm, Sweden.
²⁹ Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
³⁰ Department of Clinical Sciences at Danderyds Hospital, Karolinska Institutet, Stockholm, Sweden.
³¹ Department of Applied Health Research, University College London, London, UK.
³² Institute of Biomedicine, University of Turku, Turku, Finland.
³³ Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, Turku, Finland.
³⁴ Department of Urology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
³⁵ Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland.
³⁶ Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
³⁷ Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
³⁸ Division of Cancer Sciences, Manchester Cancer Research Centre, Manchester Academic Health Science Centre and Christie NHS Foundation Trust, University of Manchester, Manchester, UK.
³⁹ Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK.
⁴⁰ Department of Epidemiology, Harvard T.H., Chan School of Public Health, Boston, MA, USA.
⁴¹ Washington University School of Medicine, St. Louis, MO, USA.
⁴² UPMC Sorbonne Universités, GRC no. 5 ONCOTYPE-URO, Tenon Hospital, Paris, France.
⁴³ CeRePP, Tenon Hospital, Paris, France.
⁴⁴ Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
⁴⁵ Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
⁴⁶ Department of Urology, Aarhus University Hospital, Aarhus, Denmark.
⁴⁷ Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
⁴⁸ Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
⁴⁹ Cancer Research UK, Cambridge Research Institute, Cambridge, UK.
⁵⁰ Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK, Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, UK.
⁵¹ School of Social and Community Medicine, University of Bristol, Bristol, UK.
⁵² Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
⁵³ Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
⁵⁴ Division of Urology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
⁵⁵ Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁵⁶ Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁵⁷ Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA.
⁵⁸ Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA.
⁵⁹ Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
⁶⁰ Second Military Medical University, Shanghai, China.
⁶¹ Wuxi Second Hospital, Nanjing Medical University, Wuxi, China.
⁶² Department of Urology, First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
⁶³ Department of Urology, Zhongshan Hospital, Fudan University Medical College, Shanghai, China.
⁶⁴ People's Hospital of Liaoning Province, People's Hospital of China Medical University, Shenyang, China.
⁶⁵ Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
⁶⁶ Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
⁶⁷ Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
⁶⁸ Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
⁶⁹ Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA, USA.
⁷⁰ Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
⁷¹ Division of Family Medicine, Department of Neurobiology, Care Science and Society, Karolinska, Institutet, Huddinge, Sweden.
⁷² Scandinavian Development Services, Danderyd, Sweden.
⁷³ ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
⁷⁴ CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
⁷⁵ IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
⁷⁶ Universitat Pompeu Fabra (UPF), Barcelona, Spain.
⁷⁷ University of Cantabria-IDIVAL, Santander, Spain.
⁷⁸ Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
⁷⁹ Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
⁸⁰ Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
⁸¹ Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
⁸² Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.
⁸³ International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
⁸⁴ National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
⁸⁵ Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
⁸⁶ Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
⁸⁷ Department of Urology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
⁸⁸ Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
⁸⁹ Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁹⁰ German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁹¹ Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
⁹² Saarland Cancer Registry, Saarbrücken, Germany.
⁹³ Institute for Human Genetics, University Hospital Ulm, Ulm, Germany.
⁹⁴ Department of Urology, University Hospital Ulm, Ulm, Germany.
⁹⁵ Department of Genitourinary Medical Oncology, University of Texas-MD Anderson Cancer Center, Houston, TX, USA.
⁹⁶ Cancer Prevention Institute of California, Fremont, CA, USA.
⁹⁷ Department of Health Research & Policy (Epidemiology) and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
⁹⁸ Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal.
⁹⁹ Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal.
¹⁰⁰ Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, USA.
¹⁰¹ Faculty of Medicine and Health Sciences, Basic Medical Sciences, Ghent University, Ghent, Belgium.
¹⁰² Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium.
¹⁰³ Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
¹⁰⁴ Cancer Research Malaysia (CRM), Outpatient Centre, Subang Jaya Medical Centre, Selangor, Malaysia.
¹⁰⁵ Department of Urology, University of Washington, Seattle, WA, USA.
¹⁰⁶ Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
¹⁰⁷ Department of Oncology, Division of Medical Oncology, Urogenital Unit, University Hospital Centre Zagreb, Zagreb, Croatia.
¹⁰⁸ Department of Urology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.
¹⁰⁹ Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria.
¹¹⁰ Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.
¹¹¹ Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.
¹¹² Department of Urology and Alexandrovska University Hospital, Medical University of Sofia, Sofia, Bulgaria.
¹¹³ Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
¹¹⁴ Department of Urology, University Hospitals Leuven, Leuven, Belgium.
¹¹⁵ University of Southampton, Southampton General Hospital, Southampton, UK.
¹¹⁶ Division of Cancer Sciences, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Center, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, Manchester, UK.
¹¹⁷ University of Surrey, Guildford, Surrey, UK.
¹¹⁸ Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, Santiago de Compostela, Spain.
¹¹⁹ Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
¹²⁰ Genetic Oncology Unit, CHUVI Hospital, Instituto de Investigación Biomédica Galicia Sur (IISGS), Complexo Hospitalario Universitario de Vigo, Vigo, Spain.
¹²¹ Department of Family Medicine and Public Health, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
¹²² Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.
¹²³ Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands.
¹²⁴ Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.
¹²⁵ Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.
¹²⁶ Clinical Gerontology Unit, University of Cambridge, Cambridge, UK.
¹²⁷ Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
¹²⁸ George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, USA.
¹²⁹ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
¹³⁰ Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
¹³¹ Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
¹³² Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
¹³³ Genomics England, Queen Mary University of London, London, UK.
¹³⁴ Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹³⁵ Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
¹³⁶ Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
¹³⁷ Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
¹³⁸ Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
¹³⁹ Institute of Cancer Research, London, UK. ros.eeles@icr.ac.uk.
¹⁴⁰ Royal Marsden NHS Foundation Trust, London, UK. ros.eeles@icr.ac.uk.

PMID: 30622367
DOI: 10.1038/s41588-018-0330-6

Published Erratum

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Fredrick R Schumacher et al. Nat Genet. 2019 Feb.

. 2019 Feb;51(2):363.

doi: 10.1038/s41588-018-0330-6.

Authors

Affiliations

¹ Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.
² Seidman Cancer Center, University Hospitals, Cleveland, OH, USA.
³ Royal Marsden NHS Foundation Trust, London, UK.
⁴ Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK. aa461@medschl.cam.ac.uk.
⁵ Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. aa461@medschl.cam.ac.uk.
⁶ Royal Marsden NHS Foundation Trust, London, UK. aa461@medschl.cam.ac.uk.
⁷ Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA.
⁸ Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
⁹ Institute of Cancer Research, London, UK.
¹⁰ Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
¹¹ Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, Spain.
¹² Department of Oncology, Centre for Cancer Genetic Epidemiology, Strangeways Laboratory, University of Cambridge, Cambridge, UK.
¹³ Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK.
¹⁴ Warwick Medical School, University of Warwick, Coventry, UK.
¹⁵ Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA.
¹⁶ SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
¹⁷ CHRISTUS Santa Rosa Hospital-Medical Center, San Antonio, TX, USA.
¹⁸ Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
¹⁹ Australian Prostate Cancer Research Centre-Qld, Translational Research Institute, Brisbane, Queensland, Australia.
²⁰ Menzies Health Institute of Queensland, Griffith University, Nathan, Queensland, Australia.
²¹ Cancer Council Queensland, Fortitude Valley, Queensland, Australia.
²² Chris O'Brien Lifehouse (COBLH), Camperdown, New South Wales, Australia.
²³ Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
²⁴ Dame Roma Mitchell Cancer Research Centre, University of Adelaide, Adelaide, South Australia, Australia.
²⁵ Monash Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Program, Department of Anatomy and Developmental Biology, Monash University, Victoria, Australia.
²⁶ Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.
²⁷ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
²⁸ Department of Urology, Karolinska University Hospital, Stockholm, Sweden.
²⁹ Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
³⁰ Department of Clinical Sciences at Danderyds Hospital, Karolinska Institutet, Stockholm, Sweden.
³¹ Department of Applied Health Research, University College London, London, UK.
³² Institute of Biomedicine, University of Turku, Turku, Finland.
³³ Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, Turku, Finland.
³⁴ Department of Urology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
³⁵ Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland.
³⁶ Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
³⁷ Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
³⁸ Division of Cancer Sciences, Manchester Cancer Research Centre, Manchester Academic Health Science Centre and Christie NHS Foundation Trust, University of Manchester, Manchester, UK.
³⁹ Department of Oncology, Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge, Cambridge, UK.
⁴⁰ Department of Epidemiology, Harvard T.H., Chan School of Public Health, Boston, MA, USA.
⁴¹ Washington University School of Medicine, St. Louis, MO, USA.
⁴² UPMC Sorbonne Universités, GRC no. 5 ONCOTYPE-URO, Tenon Hospital, Paris, France.
⁴³ CeRePP, Tenon Hospital, Paris, France.
⁴⁴ Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
⁴⁵ Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
⁴⁶ Department of Urology, Aarhus University Hospital, Aarhus, Denmark.
⁴⁷ Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
⁴⁸ Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
⁴⁹ Cancer Research UK, Cambridge Research Institute, Cambridge, UK.
⁵⁰ Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK, Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, UK.
⁵¹ School of Social and Community Medicine, University of Bristol, Bristol, UK.
⁵² Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
⁵³ Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
⁵⁴ Division of Urology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
⁵⁵ Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁵⁶ Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁵⁷ Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA.
⁵⁸ Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA.
⁵⁹ Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
⁶⁰ Second Military Medical University, Shanghai, China.
⁶¹ Wuxi Second Hospital, Nanjing Medical University, Wuxi, China.
⁶² Department of Urology, First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
⁶³ Department of Urology, Zhongshan Hospital, Fudan University Medical College, Shanghai, China.
⁶⁴ People's Hospital of Liaoning Province, People's Hospital of China Medical University, Shenyang, China.
⁶⁵ Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
⁶⁶ Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
⁶⁷ Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
⁶⁸ Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
⁶⁹ Division of Urologic Surgery, Brigham and Womens Hospital, Boston, MA, USA.
⁷⁰ Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
⁷¹ Division of Family Medicine, Department of Neurobiology, Care Science and Society, Karolinska, Institutet, Huddinge, Sweden.
⁷² Scandinavian Development Services, Danderyd, Sweden.
⁷³ ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
⁷⁴ CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
⁷⁵ IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
⁷⁶ Universitat Pompeu Fabra (UPF), Barcelona, Spain.
⁷⁷ University of Cantabria-IDIVAL, Santander, Spain.
⁷⁸ Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
⁷⁹ Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
⁸⁰ Biostatistics Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
⁸¹ Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
⁸² Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA.
⁸³ International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
⁸⁴ National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
⁸⁵ Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
⁸⁶ Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
⁸⁷ Department of Urology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
⁸⁸ Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
⁸⁹ Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁹⁰ German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁹¹ Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
⁹² Saarland Cancer Registry, Saarbrücken, Germany.
⁹³ Institute for Human Genetics, University Hospital Ulm, Ulm, Germany.
⁹⁴ Department of Urology, University Hospital Ulm, Ulm, Germany.
⁹⁵ Department of Genitourinary Medical Oncology, University of Texas-MD Anderson Cancer Center, Houston, TX, USA.
⁹⁶ Cancer Prevention Institute of California, Fremont, CA, USA.
⁹⁷ Department of Health Research & Policy (Epidemiology) and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
⁹⁸ Department of Genetics, Portuguese Oncology Institute of Porto, Porto, Portugal.
⁹⁹ Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal.
¹⁰⁰ Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, USA.
¹⁰¹ Faculty of Medicine and Health Sciences, Basic Medical Sciences, Ghent University, Ghent, Belgium.
¹⁰² Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium.
¹⁰³ Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
¹⁰⁴ Cancer Research Malaysia (CRM), Outpatient Centre, Subang Jaya Medical Centre, Selangor, Malaysia.
¹⁰⁵ Department of Urology, University of Washington, Seattle, WA, USA.
¹⁰⁶ Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
¹⁰⁷ Department of Oncology, Division of Medical Oncology, Urogenital Unit, University Hospital Centre Zagreb, Zagreb, Croatia.
¹⁰⁸ Department of Urology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.
¹⁰⁹ Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria.
¹¹⁰ Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.
¹¹¹ Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.
¹¹² Department of Urology and Alexandrovska University Hospital, Medical University of Sofia, Sofia, Bulgaria.
¹¹³ Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
¹¹⁴ Department of Urology, University Hospitals Leuven, Leuven, Belgium.
¹¹⁵ University of Southampton, Southampton General Hospital, Southampton, UK.
¹¹⁶ Division of Cancer Sciences, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Center, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, Manchester, UK.
¹¹⁷ University of Surrey, Guildford, Surrey, UK.
¹¹⁸ Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saúde, SERGAS, Santiago de Compostela, Spain.
¹¹⁹ Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
¹²⁰ Genetic Oncology Unit, CHUVI Hospital, Instituto de Investigación Biomédica Galicia Sur (IISGS), Complexo Hospitalario Universitario de Vigo, Vigo, Spain.
¹²¹ Department of Family Medicine and Public Health, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
¹²² Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.
¹²³ Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands.
¹²⁴ Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.
¹²⁵ Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.
¹²⁶ Clinical Gerontology Unit, University of Cambridge, Cambridge, UK.
¹²⁷ Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
¹²⁸ George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, USA.
¹²⁹ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
¹³⁰ Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
¹³¹ Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
¹³² Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
¹³³ Genomics England, Queen Mary University of London, London, UK.
¹³⁴ Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹³⁵ Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
¹³⁶ Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
¹³⁷ Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
¹³⁸ Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
¹³⁹ Institute of Cancer Research, London, UK. ros.eeles@icr.ac.uk.
¹⁴⁰ Royal Marsden NHS Foundation Trust, London, UK. ros.eeles@icr.ac.uk.

PMID: 30622367
DOI: 10.1038/s41588-018-0330-6

Abstract

In the version of this article initially published, the name of author Manuela Gago-Dominguez was misspelled as Manuela Gago Dominguez. The error has been corrected in the HTML and PDF version of the article.

PubMed Disclaimer

Erratum for

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger GP, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Håkansson N, West CML, Dunning AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cussenot O, Cancel-Tassin G, Koutros S, Beane Freeman LE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestga… See abstract for full author list ➔ Schumacher FR, et al. Nat Genet. 2018 Jul;50(7):928-936. doi: 10.1038/s41588-018-0142-8. Epub 2018 Jun 11. Nat Genet. 2018. PMID: 29892016 Free PMC article.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Affiliations

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Authors

Affiliations

Abstract

Erratum for

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources